Abstract
Background Although surgical methods for upper gastrointestinal tract cancer continue to advance with the aim of reducing the incidence of anastomotic leakage (AL), it remains a prevalent and serious complication. Therefore, early identification of patients at high risk for AL is necessary for timely therapeutic measures.
Methods We retrospectively identified patients with AL who underwent elective gastric/esophageal resection at our department between 2005 and 2017. Using propensity score matching, a comparison group without AL but with comparable baseline characteristics was developed. Several previously published risk scores (o-POSSUM, E-PASS, Steyerberg, NUn score) were calculated, and their predictive accuracy for presence of AL was compared.
Results Steyerberg Risk Score, o-POSSUM, and E-PASS were found to be unsuitable for early detection of an anastomotic problem. However, an increased NUn score on the fourth to seventh postoperative day was independently associated with the presence of AL. The test accuracy (0.631-0.714), sensitivity (28.9%-50.5%), and specificity (72.5%-89.5%) were marginally satisfactory. When only C-reactive protein levels were considered, similar test accuracy (0.629-0.717), sensitivity (47.5%-69.9%), and specificity values (51.5%-81.6%) were observed using a cut-off of 150 mg/l.
Conclusions The NUn score showed no superiority over CRP values in the prediction of AL. Therefore, further diagnostics should be carried out from the fourth postoperative day if the CRP is > 150 mg/l. However, large-scale registry studies and artificial intelligence may aid in more appropriate determination of patient-specific risks in the future.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Institutional Review Board of the Technische Universität Dresden, Dresden, Germany, and was conducted in compliance with the Declaration of Helsinki, according to the ICH Harmonized Tripartite Guideline for Good Clinical Practice (decision number: 224062017). Due to the retrospective study design the ethics committee waived the requirement for informed consent. Before the data were accessed for research purposes at 18.03.2020 all data were fully anonymized.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All relevant data are within the manuscript and its Supporting Information files.